XPeng
XPEV
9.58
+0.02
+0.21%
XPeng
US · XPEV
#1584 by market cap
Listed 2020
9.58
+0.02
+0.21%
Live - 5344 symbols - heartbeat 227s ago
· 2026-10-08 08:39
Pre-market
9.56
-0.21%
After-hours
9.58
0.00%
Overnight
9.52
-0.63%
- Market cap
- 9.19B
- P/E (TTM)i
- -19.75
- P/Bi
- 2.28
- EPSi
- -0.18
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on XPEV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.21, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +87.73% YoY
Margins
- Gross margin
- 18.86%
- Operating margin
- -3.46%
- Net margin
- -1.49%
Key ratios & quality
- Enterprise valuei
- -11.20B
- Altman Z-Scorei
- 0.21
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.71M | 2.32B | 5.84B | 20.99B | 26.86B | 30.68B | 40.87B | 76.72B |
| Gross profit | -2.36M | -558.14M | 265.99M | 2.62B | 3.09B | 451.16M | 5.85B | 14.47B |
| Selling & admin expenses | 642.54M | 1.16B | 2.92B | 5.31B | 6.69B | 6.56B | 6.87B | 9.40B |
| Research & development | 1.05B | 2.07B | 1.73B | 4.11B | 5.21B | 5.28B | 6.46B | 9.49B |
| Operating profit | -1.69B | -3.78B | -4.29B | -6.58B | -8.71B | -10.92B | -6.89B | -2.65B |
| Pretax profit | -1.40B | -3.69B | -2.73B | -4.84B | -9.12B | -10.39B | -5.83B | -1.16B |
| Tax | 0 | 1.00K | 1.22M | 25.99M | 24.73M | 36.81M | -69.78M | 13.59M |
| Net profit | -1.40B | -3.69B | -2.73B | -4.86B | -9.14B | -10.38B | -5.79B | -1.14B |
| Basic EPS | -3 | -6 | -13 | -6 | -11 | -12 | -6 | -1 |
| Diluted EPS | -2.84 | -5.84 | -12.96 | -5.92 | -10.68 | -11.92 | -6.12 | -1.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 15.81B | 18.27B | 20.38B | 22.25B | 13.03B | 19.74B |
| Gross profit | 2.46B | 3.17B | 4.10B | 4.74B | 2.68B | 4.08B |
| Selling & admin expenses | 1.95B | 2.17B | 2.49B | 2.79B | 1.88B | 2.50B |
| Research & development | 1.98B | 2.21B | 2.43B | 2.87B | 2.91B | 2.91B |
| Operating profit | -923.22M | -968.65M | -677.22M | -85.00M | -1.93B | -1.19B |
| Pretax profit | -648.78M | -531.05M | -393.70M | 416.72M | -1.76B | -1.27B |
| Tax | 7.99M | -9.42M | -7.11M | 22.13M | 9.25M | 74.28M |
| Net profit | -664.05M | -477.75M | -380.87M | 383.21M | -1.78B | -1.34B |
| Basic EPS | -1 | -1 | 0 | 0 | -2 | -1 |
| Diluted EPS | -0.70 | -0.50 | -0.40 | 0.40 | -1.86 | -1.40 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 6.11B | 4.96B | 39.68B | 48.83B | 43.53B | 54.52B | 49.74B | 63.25B |
| Cash & ST investments | 4.63B | 2.35B | 33.01B | 39.72B | 31.22B | 38.72B | 32.72B | 34.96B |
| Inventory | 169.33M | 454.12M | 1.34B | 2.66B | 4.52B | 5.53B | 5.56B | 10.38B |
| Total assets | 7.67B | 9.25B | 44.71B | 65.65B | 71.49B | 84.16B | 82.71B | 103.16B |
| Total current liabilities | 972.99M | 3.30B | 7.84B | 18.01B | 24.11B | 36.11B | 39.86B | 58.11B |
| Short-term debt | 283.58M | 570.69M | 292.47M | 480.08M | 3.80B | 6.20B | 6.83B | 7.81B |
| Long-term debt | 1.00B | 1.69B | 1.65B | 3.38B | 6.38B | 6.93B | 6.98B | 6.76B |
| Total liabilities | 9,858,413,000.00 | 16,081,795,000.00 | 10,276,970,000.00 | 23,504,724,000.00 | 34,580,341,000.00 | 47,834,014,000.00 | 51,431,317,000.00 | 72,794,040,000.00 |
| Total equity | -2.19B | -6.83B | 34.43B | 42.15B | 36.91B | 36.33B | 31.27B | 30.37B |
| Retained earnings | -2.18B | -6.82B | -11.32B | -16.19B | -25.33B | -35.76B | -41.59B | -42.77B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 52.01B | 54.77B | 59.95B | 63.25B | 60.67B | 61.51B |
| Cash & ST investments | 32.51B | 33.87B | 34.70B | 34.96B | 27.14B | 28.04B |
| Inventory | 5.97B | 6.60B | 9.24B | 10.38B | 13.29B | 13.73B |
| Total assets | 88.89B | 92.43B | 98.31B | 103.16B | 100.81B | 101.59B |
| Total current liabilities | 42.93B | 47.96B | 53.57B | 58.11B | 53.33B | 55.31B |
| Short-term debt | 6.50B | 20.84B | 23.23B | 7.81B | 25.78B | 25.15B |
| Long-term debt | 5.84B | 5.96B | 6.42B | 6.76B | 9.00B | 9.15B |
| Total liabilities | 58,183,893,000.00 | 62,089,592,000.00 | 68,317,329,000.00 | 72,794,040,000.00 | 72,352,969,000.00 | 74,577,464,000.00 |
| Total equity | 30.71B | 30.34B | 29.99B | 30.37B | 28.46B | 27.01B |
| Retained earnings | -42.26B | -42.74B | -43.13B | -42.77B | -44.57B | -45.91B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.57B | -3.56B | -139.77M | -1.09B | -8.23B | 956.16M | -2.01B | 8.26B |
| Depreciation & amortization | 95.63M | 226.67M | 437.94M | 837.80M | 1.41B | 2.11B | 2.57B | 2.99B |
| Free cash flow | -2.58B | -5.47B | -1.50B | -5.41B | -12.91B | -1.36B | -4.44B | 4.91B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 27.40B | 13.15B | 0 | 5.02B | 0 | 0 |
| Ending cash balance | 1.63B | 2.41B | 31.54B | 11.63B | 14.71B | 24.30B | 21.74B | 23.40B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -35.43 | -12.70 | -23.12 | -28.33 | -17.13 | -3.70 |
| ROA %i | -29.39 | -43.95 | -18.12 | -8.81 | -13.33 | -13.33 | -6.94 | -1.23 |
| ROIC %i | -- | -- | -30.59 | -13.10 | -20.68 | -21.92 | -13.76 | -3.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -23.34 | -17.00 |
| EBIT margin %i | -14,351.96 | -157.66 | -46.34 | -22.78 | -33.46 | -33.01 | -13.43 | -1.01 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | 6.40 |
| Current ratioi | 6.28 | 1.50 | 5.06 | 2.71 | 1.81 | 1.51 | 1.25 | 1.09 |
| Quick ratioi | 5.88 | 1.12 | 4.44 | 2.44 | 1.57 | 1.24 | 1.00 | 0.76 |
| Debt / assetsi | 20.21 | 28.34 | 5.12 | 7.70 | 17.94 | 18.29 | 19.27 | 18.95 |
| LT debt / equityi | -- | -- | 5.80 | 10.85 | 24.46 | 25.31 | 29.11 | 38.67 |
| Interest coveragei | -239.27 | -114.30 | -120.63 | -86.41 | -67.98 | -37.69 | -15.95 | -2.04 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 1,193.14 | 126.17 | 73.79 | 24.87 | 41.89 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -15.45 | -13.30 | -- | -3.70 | -7.64 | -10.88 |
| ROA %i | -6.03 | -5.11 | -- | -1.23 | -2.38 | -3.22 |
| ROIC %i | -12.19 | -9.15 | -- | -3.56 | -4.72 | -5.44 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -9.44 | -6.51 | -- | -1.01 | -2.51 | -3.37 |
| FCF / sales %i | -- | 16.96 | -- | 6.40 | -- | -- |
| Current ratioi | 1.21 | 1.14 | 1.12 | 1.09 | 1.14 | 1.11 |
| Quick ratioi | 0.86 | 0.85 | 0.73 | 0.76 | 0.59 | 0.68 |
| Debt / assetsi | 19.91 | 34.63 | 35.30 | 18.95 | 41.17 | 40.38 |
| LT debt / equityi | 36.47 | 36.81 | 38.25 | 38.67 | 55.22 | 58.75 |
| Interest coveragei | -12.20 | -10.28 | -- | -2.04 | -4.46 | -5.46 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Vehicle sales and the related business100.00%
Region
People's Republic of China (PRC)100.00%
Quote time 2026-10-08 08:39:58 · For reference only, not investment advice and not tailored to your situation.